From: Time-dependent effect of GLP-1 receptor agonists on cardiovascular benefits: a real-world study
 | HR (95% CI) | p |
---|---|---|
Primary prevention | ||
Age at beginning of GLP1, years | 1.08 (1.03–1.14) | 0.001 |
GLP-1 RA withdrawal by time | 3.40 (1.82–6.32) | < 0.001 |
Secondary prevention | ||
GLP-1 RA withdrawal by time | 2.71 (1.46–5.01) | 0.002 |